VR Integrated Into Multicomponent Interventions for Improving Sleep in ICU

Status Recruiting

Clinical Trial Summary

Background: The patients who are admitted to ICUs mostly experience sleep disturbance. Seeking an effective strategy and integrating it into the daily routine is of clinical importance. Therefore, we aim to examine the effects of guided virtual reality integrated into the multicomponent program (SLEEP care) on sleep quality and quantity in critically ill patients. This will be a randomized controlled trial with assessor-blinded and two-arm parallel-group design. A total of 120 critical ill adults will be randomly allocated to the SLEEP care group and eyemask groups in a 1:1 ratio (60 participants in each group).

Clinical Trial Description

This study is expected to enroll 120 critically ill patients. We will collect basic data on the first day of admission to the intensive care unit, including demographics and disease characteristics, pain, anxiety, and stress, sleep quality and quantity, measure 5-minute HRV, wear an actigraph watch, and connect to the on-lead EEG sensor, and attach the brain wave to monitor the brain wave and sleep cycle. Then they will be randomly assigned 1:1, dividing into SLEEP care group and eyemask group. Participants who are in the control will receive eyemask intervention and daily care in the ICU. Participants who are assigned to the SLEEP care group will receive the VR and night sleep promotion routine. The researcher will assist participants to wear a virtual reality helmet for a 30-minute program at 10 pm, and then remove the helmet and wear eye masks until 6:30 in the morning. The ICU routine care of promoting sleep is still maintained. The next morning (the second day of the ICU), the researcher will assist participants to remove EEG sensors and evaluate the RCSQ scale to understand the previous night's sleep. The above process will repeat for three days (ICU days 1 to 3) until the intervention and measurement during the intensive care unit are completed on the morning of the fourth day. In order to understand the impact of sleep on cognitive function during the stay in the intensive care units and after discharge, the PSQI, VAS of pain, anxiety, and stress (confounders), and MOCA will be evaluated in the first and sixth months after discharge. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05518955
Study type	Interventional
Source	Taipei Medical University
Contact	Hsiao-Yean Chiu
Phone	+886-2-27361661
Email	hychiu0315@tmu.edu.tw
Status	Recruiting
Phase	N/A
Start date	September 20, 2022
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05114551` - ICU Predictive Score of WEaning Success in Patients At Risk of Extubation Failure
Completed	`NCT05547646` - The Prevalence of Healthcare-associated Infection in Medical Intensive Care Units in Tunisia
Recruiting	`NCT03697785` - Weaning Algorithm for Mechanical VEntilation	N/A
Completed	`NCT02922101` - Evaluation of the Effectiveness of an Audit and Feedback Intervention With Quality Improvement Toolbox in Intensive Care	N/A
Completed	`NCT02902783` - DONATE-Pilot Study on ICU Management of Deceased Organ Donors
Completed	`NCT01885442` - TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients	N/A
Completed	`NCT01857986` - Evaluating Air Leak Detection in Intubated Patients	N/A
Recruiting	`NCT03810768` - Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
Completed	`NCT03295630` - Validity of an Actigraph Accelerometer Following Critical Illness	N/A
Recruiting	`NCT05556811` - HEaling LIght Algorithms for the ICU Patient	N/A
Recruiting	`NCT05702411` - Air Stacking Technique For Pulmonary Reexpansion	N/A
Completed	`NCT02741453` - Bilateral Internal Jugular Veins Ultrasound Scanning Prior to CVC Placement	N/A
Recruiting	`NCT04979897` - Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic
Completed	`NCT05281224` - Ventilator Tube Holder for Patients With a Tracheostomy
Withdrawn	`NCT02970903` - VitalPAD: an Intelligent Monitoring and Communication Device to Optimize Safety in the PICU	N/A
Recruiting	`NCT02587273` - The Pharmacokinetics of Fentanyl in Intensive Care Patients	Phase 4
Completed	`NCT02661607` - Point of Care Echocardiography Versus Chest Radiography for the Assessment of Central Venous Catheter Placement	N/A
Completed	`NCT01479153` - Venous Site for Central Catheterization	N/A
Recruiting	`NCT06110390` - High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients	N/A
Not yet recruiting	`NCT05593380` - The Effect of BIA Monitoring of Brain Edema on the Neurological Prognosis of Supratentorial Massive ICH	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.